Cariprazine
Vraylar
Atypical Antipsychotic
NADAC/unit
$50.9144
No Shortage
Tier 1: 71.7%
PA Req: 93.6%
Cariprazine treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
vs. brand Vraylar: Generic saves up to -409% per unit
Generic Manufacturers
ABBVIE INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
